EPAS1 and neoplasm: In a previous study, we confirmed that abnormal expression of EPAS1 is involved in tumor proliferation, invasion, and angiogenesis, and is related to the resistance of breast cancer to chemotherapy; however, whether EPAS1 has other functions in breast cancer and its upstream regulatory molecules are unclear.